Search research articles
Contact Us
Filters
Showing results (11-20 of 416) with videos related to
Page
of 42
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
September 14, 2004
[HCV and extrahepatic manifestations]
Yumiko Nagao, Michio Sata
Cytotherapy
|
February 26, 2009
Therapeutic leukocytapheresis in inflammatory bowel disease: clinical efficacy and mechanisms of action
Keiichi Mitsuyama, Michio Sata
Hepatitis Monthly
|
April 16, 2014
Disappearance of Oral Lichen Planus After Liver Transplantation for Primary Biliary Cirrhosis and Immunosuppressive Therapy in a 63-year-Old Japanese Woman
Yumiko Nagao, Michio Sata
Expert Opinion on Therapeutic Targets
|
February 14, 2008
Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease
Keiichi Mitsuyama, Michio Sata
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
November 22, 2011
[Lamivudine, adefovir dipivoxil]
Ichiro Miyajima, Michio Sata
Virology Journal
|
January 4, 2011
Serum albumin and mortality risk in a hyperendemic area of HCV infection in Japan
Yumiko Nagao, Michio Sata
Biomedical Reports
|
March 21, 2014
Oral verrucous carcinoma arising from lichen planus and esophageal squamous cell carcinoma in a patient with hepatitis C virus-related liver cirrhosis-hyperinsulinemia and malignant transformation: A case report
Yumiko Nagao, Michio Sata
BMC Research Notes
|
August 31, 2012
Analysis of the factors motivating HCV-infected patients to accept interferon therapy
Yumiko Nagao, Michio Sata
Journal of Gastroenterology
|
March 17, 2005
Immunoregulatory cytokines and intestinal inflammation
Keiichi Mitsuyama, Atsushi Toyonaga, Michio Sata
Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition
|
August 16, 2013
Effects of oral branched-chain amino acids on hepatic encephalopathy and outcome in patients with liver cirrhosis
Takumi Kawaguchi, Eitaro Taniguchi, Michio Sata
Page
of 42
Search research articles
Search
Showing results (11-20 of 416) with videos related to
Sort By:
Page
of 42
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
September 14, 2004
[HCV and extrahepatic manifestations]
Yumiko Nagao, Michio Sata
Cytotherapy
|
February 26, 2009
Therapeutic leukocytapheresis in inflammatory bowel disease: clinical efficacy and mechanisms of action
Keiichi Mitsuyama, Michio Sata
Hepatitis Monthly
|
April 16, 2014
Disappearance of Oral Lichen Planus After Liver Transplantation for Primary Biliary Cirrhosis and Immunosuppressive Therapy in a 63-year-Old Japanese Woman
Yumiko Nagao, Michio Sata
Expert Opinion on Therapeutic Targets
|
February 14, 2008
Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease
Keiichi Mitsuyama, Michio Sata
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
November 22, 2011
[Lamivudine, adefovir dipivoxil]
Ichiro Miyajima, Michio Sata
Virology Journal
|
January 4, 2011
Serum albumin and mortality risk in a hyperendemic area of HCV infection in Japan
Yumiko Nagao, Michio Sata
Biomedical Reports
|
March 21, 2014
Oral verrucous carcinoma arising from lichen planus and esophageal squamous cell carcinoma in a patient with hepatitis C virus-related liver cirrhosis-hyperinsulinemia and malignant transformation: A case report
Yumiko Nagao, Michio Sata
BMC Research Notes
|
August 31, 2012
Analysis of the factors motivating HCV-infected patients to accept interferon therapy
Yumiko Nagao, Michio Sata
Journal of Gastroenterology
|
March 17, 2005
Immunoregulatory cytokines and intestinal inflammation
Keiichi Mitsuyama, Atsushi Toyonaga, Michio Sata
Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition
|
August 16, 2013
Effects of oral branched-chain amino acids on hepatic encephalopathy and outcome in patients with liver cirrhosis
Takumi Kawaguchi, Eitaro Taniguchi, Michio Sata
Page
of 42